Progyny, INC Form 4 insider transactions

Melissa B Cummings, Chief Operating Officer of Progyny, Inc., sold 2,244 shares of common stock on July 14, 2026 for $31.60 per share.

Progyny CFO Mark S. Livingston sold shares and withheld stock for tax obligations under a pre-established 10b5-1 plan.

Progyny EVP and General Counsel Allison Swartz reported the sale and tax-withholding disposition of common stock.

Progyny CEO Peter Anevski reported the withholding of 5,361 shares to cover tax obligations related to the vesting of restricted stock units.

Progyny's Chief Financial Officer, Mark S. Livingston, reported transactions involving the sale of company stock, including shares withheld for tax payments and shares sold under a pre-arranged trading plan.

Progyny Director Cheryl Scott reports transactions involving common stock and stock options, including acquisitions and dispositions.

Progyny Chief Product Officer Geoffrey Clapp executed a series of transactions involving Progyny, Inc. (PGNY) common stock on June 2, 2026.

Progyny, Inc. Director Elizabeth D. Bierbower acquired stock options and restricted stock units (RSUs) on May 21, 2026, as detailed in a Form 4 filing.

Progyny, Inc. Director Lloyd H. Dean reported the acquisition of 6,792 shares of common stock and 28,203 stock options on May 21, 2026.

Progyny, Inc. Director Kevin Gordon reported transactions involving common stock and stock options on May 21, 2026.

Progyny, Inc. Director Roger C. Holstein reported transactions involving common stock and stock options on May 21, 2026.

Progyny, Inc. Director Jeffrey G. Park acquired 7,924 shares of common stock and was granted stock options for 36,663 shares.

Progyny, Inc. Director Norman Payson reported transactions involving restricted stock units and stock options on May 21, 2026.

Progyny, Inc. Director Cheryl Scott reported a transaction involving the acquisition of common stock and stock options.

Debra L. Morris, a Director at Progyny, Inc., has acquired shares and stock options through a transaction on May 21, 2026.

Progyny's Chief Financial Officer, Mark S. Livingston, has sold 8,275 shares of common stock for $25.50 per share, totaling $210,987.50, as part of a pre-arranged trading plan.

Progyny's Chief Operating Officer, Melissa B. Cummings, sold 9,578 shares of common stock for $25 per share under a pre-arranged 10b5-1 trading plan.

Progyny, Inc. Chief Operating Officer Melissa Cummings reported the withholding of 4,172 shares to cover tax obligations upon the vesting of restricted stock units.

Progyny's Chief Product Officer, Geoffrey Clapp, reported a disposition of 3,275 shares of common stock at $17.42 per share for tax withholding purposes.

Progyny's EVP and General Counsel, Allison Swartz, sold 599 shares of common stock on March 4, 2026, under a pre-arranged 10b5-1 trading plan.

Progyny's Chief Financial Officer, Mark S. Livingston, disposed of 339 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Progyny's Chief Product Officer, Geoffrey Clapp, was granted 35,228 restricted stock units and 51,373 stock options as part of an annual merit award.

Progyny's Chief Operating Officer, Melissa B. Cummings, was granted 45,454 restricted stock units and 66,289 stock options as part of an annual merit award.

Progyny's EVP and General Counsel, Allison Swartz, reported receiving significant equity grants while also executing pre-planned sales of common stock.

Progyny's Chief Financial Officer, Mark S. Livingston, was granted restricted stock units and stock options as part of an annual merit award, alongside tax-related share dispositions.

Progyny CEO Peter Anevski was granted restricted stock units and stock options, while also disposing of shares for tax obligations.

Progyny's Executive Chairman, David J. Schlanger, disposed of 2,171 common shares at $25.68 each to cover tax obligations from restricted stock unit vesting.

Progyny CEO Peter Anevski disposed of 6,009 shares of common stock at $25.68 per share to cover tax obligations related to restricted stock unit vesting.

Progyny's President, Michael E. Sturmer, reported a disposition of 33,028 shares of common stock for tax withholding purposes.

Progyny's Chief Financial Officer, Mark S. Livingston, sold 459 shares of common stock for $25.5 per share under a pre-arranged 10b5-1 trading plan.